EW

#317
Edwards Lifesciences Corporation Common Stock
86.1 5 USD
-1.06%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
85.84
86.72
Range Annuel
72.30
88.28
Changement quotidien
-1.06%
Changement Mensuel
+5.87%
Evolution sur 6 mois
-0.49%
Changement Annuel
+11.26%
Clôture Précédente
87.0 7
Open
85.9 7
Low
85.8 4
High
86.7 2
Volume
716
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 49.61 B
  • Employee 16 K
  • Founded N/A
  • CEO -
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
46.58
ratio cours/chiffre d'affaires
8.26

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

Nouvelles